SEL Manufacturing Peer Comparison

NSE: SELMC | BSE: 532886

₹22.65

₹-1.19 (-4.99%)

As on 12-Oct-2026IST

Market cap

₹77 Cr

Revenue (TTM)

₹13 Cr

P/E Ratio

P/B Ratio

-0.2

Div. Yield

0 %

Edit

	SEL Manufacturing	Welspun Living	Sheela Foam	Wakefit Innovations	Euro Pratik Sales
Market cap (₹ Cr)	77	20,704	6,737	4,572	1,868
Revenue (₹ Cr)	13	9,934	4,031	1,489	374
Net Profit (₹ Cr)	-168.82	284.85	193.86	189.18	87.91
Net Margin (%)	-1,306.78	2.85	4.74	12.33	22.95
RoE (%)	--	5.70	6.34	23.67	29.87
Price to Earnings	--	74.58	31.41	24.17	21.67
Price-To-Book	-0.18	4.30	2.04	4.00	5.66

Income Statement (₹ Cr)

	SEL Manufacturing	Welspun Living	Sheela Foam	Wakefit Innovations	Euro Pratik Sales
Operating Revenue	32.87	10,545.09	3,439.20	1,273.69	284.23
Total Income	33.15	10,697.24	3,570.12	1,305.43	293.70
Total Expenditure	42.64	9,246.59	3,194.22	1,213.81	185.88
EBITDA	-9.77	1,298.50	244.98	59.88	98.35
Depreciation	93.74	373.39	182.61	96.24	5.46
EBIT	-103.51	925.11	62.37	-36.36	92.89
Interest	69.74	217.47	120.55	30.38	4.00
Other Income	0.28	152.15	130.92	31.74	9.48
Exceptional Items	42.25	--	30.59	--	--
Profit before Tax	-130.72	860.18	103.33	-35.00	99.78
Provision for Tax	--	216.16	14.41	--	24.09
Profit after Tax	-130.72	644.02	88.92	-35.00	75.69

	SEL Manufacturing	Welspun Living	Sheela Foam	Wakefit Innovations	Euro Pratik Sales
Shareholder's Funds	-209.11	4,821.09	3,016.66	520.57	234.11
Minority Interest	--	99.57	7.49	--	0.39
Non-Current Liabilities	653.36	2,093.80	894.98	210.80	13.42
Current Liabilities	504.20	3,252.86	1,480.48	319.38	23.87
Total Liabilities	948.46	10,267.32	5,548.53	1,050.75	273.85

	SEL Manufacturing	Welspun Living	Sheela Foam	Wakefit Innovations	Euro Pratik Sales
Non-Current Assets	930.64	4,798.73	3,940.93	513.27	38.63
Current Assets	17.82	5,468.59	1,400.46	537.48	233.16
Total Assets	948.46	10,267.32	5,548.53	1,050.75	273.85
Total Debt*	961.34	2,468.62	1,216.49	0.00	2.69
Net Current Assets	-486.38	2,215.73	-80.02	218.10	209.29
Contingent Liabilities	1.86	57.50	57.38	5.72	--

	SEL Manufacturing	Welspun Living	Sheela Foam	Wakefit Innovations	Euro Pratik Sales
Cash From Operating Activities	67.00	687.98	247.39	76.22	-30.66
Cash Flow from Investing Activities	2.29	57.32	-23.88	-2.11	36.04
Cash from Financing Activities	-69.70	-663.14	-226.32	-70.62	-1.87
Net Cash Inflow / Outflow	-0.41	82.16	-2.81	3.49	3.52

	SEL Manufacturing	Welspun Living	Sheela Foam	Wakefit Innovations	Euro Pratik Sales
ROCE (%)	-7.46	15.04	5.31	-0.86	52.88
ROE (%)	0.00	13.83	3.00	-7.13	38.83
ROA (%)	-13.05	6.52	1.66	-3.54	33.97
EBIT Margin (%)	-28.87	13.76	10.93	7.19	37.94
Net Margin (%)	-394.36	6.02	2.49	-2.68	25.77
Cash Profit Margin (%)	-112.50	9.23	7.15	4.81	28.55

	SEL Manufacturing	Welspun Living	Sheela Foam	Wakefit Innovations	Euro Pratik Sales
Revenue Growth (%)	-91.22	8.95	15.32	29.13	28.20
EBIT Growth (%)	82.24	-4.23	-9.99	36.64	20.53
Net Profit Growth (%)	32.25	-4.27	-54.29	-132.54	20.32
EPS Growth (%)	32.25	-4.91	-51.24	-128.55	5.44
Book Value Growth (%)	-270.83	6.55	3.08	-5.02	50.33

	SEL Manufacturing	Welspun Living	Sheela Foam	Wakefit Innovations	Euro Pratik Sales
Price / Earnings	0.00	20.27	86.86	0.00	0.00
Price / Book Value	-0.44	2.70	2.58	0.00	0.00
Dividend Yield (%)	0.00	1.26	0.00	--	--
EV/EBITDA	-110.66	10.42	23.76	0.11	-0.01
Market Cap (₹ Cr)	91.62	12,952.53	7,760.55	0.00	0.00

	SEL Manufacturing	Welspun Living	Sheela Foam	Wakefit Innovations	Euro Pratik Sales
Debt to Equity	-4.60	0.51	0.40	0.00	0.01
Short term debt to equity ratio	--	0.30	0.04	0.01	0.01
Current Ratio	0.04	1.68	0.95	1.68	9.77
Quick Ratio	0.02	1.01	0.71	1.17	5.74
Interest Coverage	-0.87	4.96	1.86	-0.15	25.94

	SEL Manufacturing	Welspun Living	Sheela Foam	Wakefit Innovations	Euro Pratik Sales
Debtors to sales (%)	2.64	15.60	10.05	0.46	33.72
Asset Turnover	0.03	1.12	0.71	1.29	1.28
Receivable days	9.34	47.98	34.08	4.86	90.02
Inventory Days	145.38	70.42	33.12	42.17	84.61
Payable days	1,278.81	69.75	63.51	95.95	9.53
Cash Conversion Cycle	-1,124.09	48.65	3.69	-48.91	165.10

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.